Zhaohui Ni Selected Research

Calcium Dobesilate

1/2019	Investigation of the Mechanism Underlying Calcium Dobesilate-Mediated Improvement of Endothelial Dysfunction and Inflammation Caused by High Glucose.
1/2018	Diabetic Nephropathy Can Be Treated with Calcium Dobesilate by Alleviating the Chronic Inflammatory State and Improving Endothelial Cell Function.
12/2017	Calcium dobesilate may alleviate diabetes‑induced endothelial dysfunction and inflammation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zhaohui Ni Research Topics

Disease

20	Chronic Kidney Failure (Chronic Renal Failure) 08/2022 - 07/2010
20	Acute Kidney Injury (Acute Renal Failure) 10/2021 - 01/2010
17	Inflammation (Inflammations) 01/2021 - 01/2007
15	Chronic Renal Insufficiency 03/2022 - 03/2008
12	IGA Glomerulonephritis (IGA Nephropathy) 01/2022 - 01/2012
8	Fibrosis (Cirrhosis) 01/2022 - 01/2009
8	Proteinuria 01/2021 - 03/2010
7	Lupus Nephritis 01/2022 - 01/2010
7	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 12/2008
6	Kidney Diseases (Kidney Disease) 01/2022 - 11/2012
6	Stomach Neoplasms (Stomach Cancer) 06/2016 - 02/2011
5	Diabetic Nephropathies (Diabetic Nephropathy) 01/2022 - 02/2006
5	Glomerulonephritis 01/2021 - 01/2012
5	Peritonitis 01/2020 - 01/2014
4	Anemia 06/2022 - 01/2019
4	Infections 01/2022 - 02/2013
4	Neoplasms (Cancer) 01/2022 - 03/2011
4	Heart Failure 01/2022 - 01/2014
4	Renal Insufficiency (Renal Failure) 12/2021 - 01/2018
4	Hypoxia (Hypoxemia) 10/2021 - 01/2014
4	Atherosclerosis 11/2018 - 01/2012
4	Albuminuria 12/2015 - 02/2006
3	Diabetes Mellitus 10/2022 - 03/2008
3	Peritoneal Fibrosis 01/2020 - 09/2017
3	Disease Progression 03/2017 - 01/2012
3	Membranous Glomerulonephritis (Membranous Nephropathy) 01/2017 - 05/2011
3	Peripheral Arterial Disease 01/2016 - 04/2013
3	Nephrosis 12/2015 - 05/2011
3	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2012 - 01/2010
2	Hypertension (High Blood Pressure) 01/2022 - 01/2018
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2022 - 03/2019
2	Glioma (Gliomas) 01/2022 - 01/2016
2	Ureteral Obstruction 01/2022 - 09/2014
2	Type 2 Diabetes Mellitus (MODY) 01/2022 - 01/2018
2	Secondary Hyperparathyroidism 11/2021 - 10/2021
2	Ischemia 02/2021 - 01/2021
2	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2019 - 01/2018
2	Malnutrition (Nutritional Deficiencies) 11/2018 - 08/2009
2	Necrosis 01/2018 - 07/2017
2	Anuria 04/2017 - 08/2015
2	Vascular Calcification 01/2017 - 01/2015
2	Insulin Resistance 09/2015 - 09/2015

Drug/Important Bio-Agent (IBA)

17	Proteins (Proteins, Gene)FDA Link 01/2021 - 08/2009
16	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2010
12	CreatinineIBA 05/2020 - 03/2008
7	InflammasomesIBA 10/2021 - 10/2016
6	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 05/2011
6	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 09/2014
5	Serum AlbuminIBA 10/2021 - 12/2008
5	AlbuminsIBA 01/2021 - 07/2014
4	Prednisone (Sone)FDA LinkGeneric 12/2021 - 12/2013
4	C-Reactive ProteinIBA 10/2021 - 01/2010
3	Hemoglobins (Hemoglobin)IBA 03/2022 - 01/2016
3	HematinicsIBA 03/2022 - 01/2019
3	Leflunomide (Arava)FDA LinkGeneric 12/2021 - 07/2017
3	IronIBA 10/2021 - 01/2019
3	Fatty Acid-Binding ProteinsIBA 02/2021 - 01/2012
3	Immunoglobulin A (IgA)IBA 01/2021 - 11/2012
3	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 07/2017
3	Dialysis SolutionsIBA 01/2020 - 01/2014
3	Contrast MediaIBA 01/2019 - 10/2016
3	Calcium DobesilateIBA 01/2019 - 12/2017
3	Interleukin-6 (Interleukin 6)IBA 01/2018 - 01/2014
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2017 - 02/2017
3	Adrenal Cortex Hormones (Corticosteroids)IBA 07/2017 - 06/2015
3	astragaloside AIBA 07/2017 - 09/2014
3	MicroRNAs (MicroRNA)IBA 03/2017 - 08/2012
2	Epoetin Alfa (Epogen)FDA Link 06/2022 - 03/2022
2	Darbepoetin alfa (Aranesp)FDA Link 06/2022 - 03/2022
2	Erythropoietin FDA Link 06/2022 - 03/2022
2	Pharmaceutical PreparationsIBA 01/2022 - 01/2022
2	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2022 - 01/2020
2	Monoclonal AntibodiesIBA 01/2021 - 06/2020
2	Cystatin CIBA 02/2020 - 01/2019
2	AntioxidantsIBA 01/2020 - 07/2017
2	CytokinesIBA 01/2020 - 04/2013
2	NLR ProteinsIBA 10/2019 - 09/2017
2	Angiopoietin-2IBA 11/2018 - 09/2017
2	Indicators and Reagents (Reagents)IBA 09/2018 - 01/2012
2	Phosphorus (Red Phosphorus)IBA 08/2018 - 08/2015
2	Messenger RNA (mRNA)IBA 04/2018 - 01/2014
2	LigandsIBA 09/2017 - 02/2006
2	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2016 - 09/2012
2	ColforsinIBA 12/2015 - 01/2014
2	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2015 - 03/2012
2	SteroidsIBA 06/2015 - 05/2011
2	PTX3 proteinIBA 01/2015 - 04/2013
2	Lipocalin-2IBA 04/2014 - 06/2012
2	SolutionsIBA 03/2013 - 03/2008
2	Lipase (Acid Lipase)FDA Link 03/2013 - 02/2011

Therapy/Procedure

23	Peritoneal Dialysis 08/2022 - 01/2012
19	Renal Dialysis (Hemodialysis) 10/2022 - 04/2013
13	Therapeutics 01/2022 - 01/2009
5	Catheters 03/2018 - 01/2014
4	Continuous Ambulatory Peritoneal Dialysis (CAPD) 01/2018 - 01/2014
4	Renal Replacement Therapy (Therapies, Renal Replacement) 11/2017 - 01/2014
3	Kidney Transplantation 02/2021 - 01/2018
2	Injections 03/2022 - 10/2019
2	Nephrectomy 10/2021 - 01/2019
2	Intraperitoneal Injections 01/2020 - 09/2014